Roles
- Assistant Professor of Clinical Dermatology & Cutaneous Surgery
- Director of Inpatient Dermatology Services, University of Miami Hospital and Clinics
- Medical Director of Outpatient Dermatology, Jackson Memorial Hospital
- Director of Connective Tissue Disease Clinic, Jackson Memorial Hospital
-
Biography
Dr. Elman received his Medical Degree from Harvard Medical School, where he stayed to complete his combined residency in internal medicine and dermatology. His clinical and research interests include complex medical dermatology, rheumatologic dermatology and inpatient dermatology. Outside of the hospital, Dr. Elman enjoys cooking, traveling and spending time with his wife and newborn daughter. -
Education & Training
Education
Post Graduate Training
Licensures and Certifications
-
Honors & Awards
-
Teaching Interests
As a dual-board certified internist and dermatologist, I enjoy teaching about the skin manifestations of systemic diseases. -
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Articles & News
2026 Faculty Awards Celebrate Excellence Across the Miller School of Medicine and UHealth
Dr. Scott Elman Joins the Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery
Disclaimer:
Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Clinical Trials
Viewing 0 of 5 clinical trials.
-
The primary objective of the study is to evaluate the efficacy of PF-06823859 in reducing muscle symptoms in adult participants with active DM and adult participants with active PM.
- Principal Investigator: Scott Elman
- Study Phase: TBD
- Enrollment Status: Open
-
The purpose of this study is to determine the safety and efficacy of brepocitinib (a tyrosine kinase [TYK]2/Janus kinase [JAK]1 inhibitor) in adult participants with active, moderate to severe lichen planopilaris (LPP).
- Principal Investigator: Scott Elman
- Study Phase: TBD
- Enrollment Status: Open
-
Researchers want to find out if a drug called IMVT-1402 is safe and helps people with active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) with or without systemic manifestations of Lupus Erythematosus.
- Principal Investigator: Scott Elman
- Study Phase: TBD
- Enrollment Status: Closed
-
To evaluate the effect of brensocatib compared with placebo.
- Principal Investigator: Scott Elman
- Study Phase: TBD
- Enrollment Status: Closed
-
To evaluate the efficacy of SCENESSE and NB-UVB compared to NB-UVB alone in repigmentation of vitiligo on the body (except head, hands and feet) after 20 weeks of treatment.
- Principal Investigator: Scott Elman
- Study Phase: TBD
- Enrollment Status: Not Accepting